Responses
Clinical and epidemiological research
Concise report
Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings
Compose a Response to This Article
Other responses
No responses have been published for this article.